Give your board a date you can defend.

A CMC vendor slips a month. A risk you logged just hit its trigger. Mark it occurred — that's all the input CritPath needs.

Every downstream task, buffer, and milestone re-cascades in seconds. The engine re-runs the full schedule math automatically — nothing is hand-dragged.

New dates on the Gantt, buffers re-checked — and on projects running Monte Carlo, a fresh read on how solid the new finish is. Ready for the meeting you're already late for.

Your Gantt shows one date and says nothing about how likely it is — so every board deck is a promise you can't back. CritPath shows how solid each date is and which tasks are quietly driving the risk.

A CMC vendor slips a month and every downstream milestone silently moves. Re-planning by hand costs your PMO a day each time. Here, you log the slip and the plan catches up in seconds.

One program PM spent eight hours a day re-typing emailed status updates. Your status report already exists — it's the live schedule. Export it, or have an AI employee draft it, every number computed.

Monte Carlo simulation — 10,000 runs over your actual dependency network — turns a single guessed date into a defensible range and the real chance of hitting your target. Your engineers already estimate in ranges; here the range survives all the way to the board deck.

Critical path plus critical chain (CCPM): the bottleneck, the buffers protecting your milestones, and a fever chart that shows margin burning before the date moves.

Go / No-Go / Pivot gates are schedule objects with named owners, co-signs, and an audit trail — and a No-Go or Pivot triggers a fresh run of the schedule math.

Resource leveling plus a staffing optimizer that shows what each hire or reassignment buys you — the speed-versus-cost trade-off, priced in days and dollars.

Configurable agents read the live schedule and propose updates for your review. Nothing touches the plan until a named human accepts — every acceptance audited.

AACE RP 132R-23 Level 4 risk-driven scheduling with a tamper-evident audit trail — built for pharma IND programs and federally funded R&D. 21 CFR Part 11 on the Enterprise roadmap.